VCMCVC Market Cap
Menu

Alan valuation, funding and investors

alan.com ↗LinkedIn ↗

Alan works in health insurance product development, based in Paris, France. Founded in 2016, it has about 1,610 employees.

Insurance - Agents, Carriers & Brokers Paris Series G
VALUATION · TODAY
$6.91B +20% after Series G
Range $5.48B – $9.56B · Grade A
TODAY
+12 MO
$2.50B
$5.00B
$7.50B
$10.00B
$12.50B
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Seed $13.1M
Series A $28.0M
Series B $45.0M
Series C $54.3M
Series D $222M
Series E
Series F $193M
Growth $115M
Series G $550M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY1,609 employees
+19%6m growth
+31%1y growth
+46%2y growth
1,000
2,000
Data from Jan 2021
TODAY
Predicted in 1 yr $8.31B +20% vs today
Predicted next raise $997M if a round comes
Winding-down probability 0%
Last round
Series G · $550M · Jun 2026
Valuation at last round
$6.30B
Headcount
1,609 · up
Grade
A
Founded
2016
How VCMC values companies →

Alan valuation today

VCMC values Alan at $6.9B today, with a range of $5.5B to $9.6B and a grade of A. The valuation starts from its last funding round, a Series G round in Jun 2026.

Valuation by date (140 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Alan: valuation by date, as the model would have shown it on each date
DateValuationRangePredicted in 1 yrPhaseHeadcountTrendGradeWinding-down probability
1 Jan 2016$4.37M$1.59M – $12.0M$5.24M (+20%)before first round–unknownD0%
1 Feb 2016$4.39M$1.60M – $12.1M$5.38M (+23%)before first round–unknownD0%
1 Mar 2016$4.41M$1.60M – $12.1M$5.52M (+25%)before first round–unknownD0%
1 Apr 2016$4.42M$1.61M – $12.1M$5.67M (+28%)before first round–unknownD0%
1 May 2016$4.44M$1.62M – $12.2M$5.82M (+31%)before first round–unknownD0%
1 Jun 2016$4.46M$1.62M – $12.2M$5.97M (+34%)before first round–unknownD0%
1 Jul 2016$4.47M$1.63M – $12.3M$6.13M (+37%)before first round–unknownD0%
1 Aug 2016$4.59M$1.67M – $12.6M$6.30M (+37%)before first round–unknownD0%
1 Sep 2016$4.72M$1.72M – $13.0M$6.47M (+37%)before first round–unknownD0%
1 Oct 2016$4.84M$1.76M – $13.3M$6.64M (+37%)before first round–unknownD0%
26 Oct 2016$48.0M$31.5M – $146M$95.8M (+100%)after a round–unknownC0%
1 Nov 2016$48.6M$31.5M – $146M$95.8M (+97%)after a round–unknownC0%
1 Dec 2016$51.4M$31.5M – $146M$95.8M (+86%)after a round–unknownC0%
1 Jan 2017$54.5M$31.5M – $146M$95.8M (+76%)after a round–unknownC0%
1 Feb 2017$57.8M$31.5M – $146M$95.8M (+66%)after a round–unknownC0%
1 Mar 2017$61.0M$31.5M – $146M$95.8M (+57%)after a round–unknownC0%
1 Apr 2017$64.7M$31.5M – $146M$95.8M (+48%)after a round–unknownC0%
1 May 2017$68.5M$31.5M – $146M$95.8M (+40%)after a round–unknownC0%
1 Jun 2017$72.6M$31.5M – $146M$95.8M (+32%)after a round–unknownC0%
1 Jul 2017$76.9M$31.5M – $146M$95.8M (+25%)after a round–unknownC0%
1 Aug 2017$81.5M$31.5M – $146M$95.8M (+18%)after a round–unknownC0%
1 Sep 2017$86.5M$31.5M – $146M$95.8M (+11%)after a round–unknownC0%
1 Oct 2017$91.5M$31.5M – $146M$95.8M (+5%)after a round–unknownC0%
1 Nov 2017$95.8M$31.1M – $146M$95.8M (0%)after a round–unknownC0%
1 Dec 2017$95.8M$29.6M – $146M$95.8M (0%)after a round–unknownC0%
1 Jan 2018$95.8M$28.2M – $146M$95.8M (0%)after a round–unknownC0%
1 Feb 2018$95.8M$26.8M – $146M$95.8M (0%)after a round–unknownC0%
1 Mar 2018$95.8M$25.6M – $146M$95.8M (0%)after a round–unknownC0%
1 Apr 2018$95.8M$24.3M – $146M$95.8M (0%)after a round–unknownC0%
11 Apr 2018$129M$90.8M – $329M$232M (+80%)after a round–unknownC0%
1 May 2018$133M$90.8M – $329M$232M (+74%)after a round–unknownC0%
1 Jun 2018$140M$90.8M – $329M$232M (+66%)after a round–unknownC0%
1 Jul 2018$147M$90.8M – $329M$232M (+58%)after a round–unknownC0%
1 Aug 2018$155M$90.8M – $329M$232M (+50%)after a round–unknownC0%
1 Sep 2018$162M$90.8M – $329M$232M (+43%)after a round–unknownC0%
1 Oct 2018$170M$90.8M – $329M$232M (+36%)after a round–unknownC0%
1 Nov 2018$179M$90.8M – $329M$232M (+29%)after a round–unknownC0%
1 Dec 2018$188M$90.8M – $329M$232M (+23%)after a round–unknownC0%
1 Jan 2019$198M$90.8M – $329M$232M (+17%)after a round–unknownC0%
1 Feb 2019$208M$90.8M – $329M$232M (+12%)after a round–unknownC0%
18 Feb 2019$271M$191M – $576M$406M (+50%)after a round–unknownB0%
1 Mar 2019$274M$191M – $576M$406M (+48%)after a round–unknownB0%
1 Apr 2019$284M$191M – $576M$406M (+43%)after a round–unknownB0%
1 May 2019$293M$191M – $576M$406M (+38%)after a round–unknownB0%
1 Jun 2019$304M$191M – $576M$406M (+34%)after a round–unknownB0%
1 Jul 2019$314M$191M – $576M$406M (+29%)after a round–unknownB0%
1 Aug 2019$325M$191M – $576M$406M (+25%)after a round–unknownB0%
1 Sep 2019$336M$191M – $576M$406M (+21%)after a round–unknownB0%
1 Oct 2019$348M$191M – $576M$406M (+17%)after a round–unknownB0%
1 Nov 2019$360M$191M – $576M$406M (+13%)after a round–unknownB0%
1 Dec 2019$372M$191M – $576M$406M (+9%)after a round–unknownB0%
1 Jan 2020$385M$191M – $576M$406M (+5%)after a round–unknownB0%
1 Feb 2020$399M$191M – $576M$406M (+2%)after a round–unknownB0%
1 Mar 2020$406M$187M – $576M$406M (0%)after a round–unknownB0%
1 Apr 2020$406M$179M – $576M$406M (0%)after a round–unknownB0%
21 Apr 2020$439M$309M – $808M$570M (+30%)after a round–unknownB0%
1 May 2020$442M$309M – $808M$570M (+29%)after a round–unknownB0%
1 Jun 2020$452M$309M – $808M$570M (+26%)after a round–unknownB0%
1 Jul 2020$461M$309M – $808M$570M (+23%)after a round–unknownB0%
1 Aug 2020$472M$309M – $808M$570M (+21%)after a round–unknownB0%
1 Sep 2020$482M$309M – $808M$570M (+18%)after a round–unknownB0%
1 Oct 2020$493M$309M – $808M$570M (+16%)after a round–unknownB0%
1 Nov 2020$504M$309M – $808M$570M (+13%)after a round–unknownB0%
1 Dec 2020$515M$309M – $808M$570M (+11%)after a round–unknownB0%
1 Jan 2021$527M$309M – $808M$570M (+8%)after a round270unknownB0%
1 Feb 2021$539M$309M – $808M$570M (+6%)after a round270unknownB0%
1 Mar 2021$549M$309M – $808M$570M (+4%)after a round270unknownB0%
1 Apr 2021$562M$309M – $808M$570M (+1%)after a round270unknownB0%
20 Apr 2021$1.7B$1.5B – $2.5B$2.2B (+30%)after a round270unknownA0%
1 May 2021$1.7B$1.5B – $2.5B$2.2B (+29%)after a round270unknownA0%
1 Jun 2021$1.7B$1.5B – $2.5B$2.2B (+26%)after a round270unknownA0%
1 Jul 2021$1.8B$1.5B – $2.5B$2.2B (+23%)after a round270unknownA0%
1 Aug 2021$1.8B$1.5B – $2.5B$2.2B (+21%)after a round270unknownA0%
1 Sep 2021$1.8B$1.5B – $2.5B$2.2B (+18%)after a round270unknownA0%
1 Oct 2021$1.9B$1.5B – $2.5B$2.2B (+15%)after a round270unknownA0%
1 Nov 2021$1.9B$1.5B – $2.5B$2.2B (+13%)after a round270unknownA0%
1 Dec 2021$2.0B$1.5B – $2.5B$2.2B (+11%)after a round270unknownA0%
1 Jan 2022$2.0B$1.5B – $2.5B$2.2B (+8%)after a round270unknownA0%
1 Feb 2022$2.1B$1.5B – $2.5B$2.2B (+6%)after a round270unknownA0%
1 Mar 2022$2.4B$1.5B – $3.0B$2.6B (+6%)after a round570growingB0%
1 Apr 2022$2.5B$1.5B – $3.0B$2.6B (+2%)after a round570growingB0%
1 May 2022$2.6B$1.5B – $3.0B$2.6B (0%)after a round570growingB0%
1 Jun 2022$2.6B$1.5B – $3.0B$2.6B (0%)after a round570growingB0%
1 Jul 2022$2.6B$1.5B – $3.0B$2.6B (0%)after a round570growingB0%
1 Aug 2022$2.6B$1.3B – $3.0B$2.6B (0%)after a round570unknownB0%
1 Sep 2022$2.6B$1.3B – $3.0B$2.6B (0%)after a round570unknownB0%
1 Oct 2022$2.6B$1.2B – $3.0B$2.6B (0%)after a round570unknownB0%
13 Oct 2022$2.6B$1.3B – $6.7B$3.3B (+30%)after a round570unknownC0%
1 Nov 2022$2.6B$1.3B – $6.7B$3.3B (+28%)after a round570unknownC0%
1 Dec 2022$2.7B$1.3B – $6.7B$3.3B (+25%)after a round570unknownC0%
1 Jan 2023$2.7B$1.3B – $6.7B$3.3B (+23%)after a round570unknownC0%
1 Feb 2023$2.8B$1.3B – $6.7B$3.3B (+20%)after a round570unknownC0%
1 Mar 2023$2.8B$1.3B – $6.7B$3.3B (+18%)after a round570unknownC0%
1 Apr 2023$2.9B$1.3B – $6.7B$3.3B (+15%)after a round570unknownC0%
1 May 2023$3.0B$1.3B – $6.7B$3.3B (+13%)after a round850growingC0%
1 Jun 2023$3.0B$1.3B – $6.7B$3.3B (+10%)after a round850growingC0%
1 Jul 2023$3.1B$1.3B – $6.7B$3.3B (+8%)after a round850growingC0%
1 Aug 2023$3.2B$1.3B – $6.7B$3.3B (+5%)after a round850growingC0%
1 Sep 2023$3.2B$1.3B – $6.7B$3.3B (+3%)after a round850unknownC0%
1 Oct 2023$3.3B$1.3B – $6.7B$3.3B (+1%)after a round850unknownC0%
1 Nov 2023$3.3B$1.3B – $6.7B$3.3B (0%)after a round860flatC0%
1 Dec 2023$3.3B$1.2B – $6.7B$3.3B (0%)after a round860flatC0%
1 Jan 2024$3.3B$1.1B – $6.7B$3.3B (0%)after a round860flatC0%
1 Feb 2024$3.3B$1.1B – $6.7B$3.3B (0%)after a round860flatC0%
1 Mar 2024$3.3B$1.0B – $6.7B$3.3B (0%)after a round860flatC0%
1 Apr 2024$3.3B$998M – $6.7B$3.3B (0%)after a round930flatC0%
1 May 2024$3.3B$954M – $6.7B$3.3B (0%)after a round930flatC0%
1 Jun 2024$3.3B$911M – $6.7B$3.3B (0%)after a round930flatC0%
1 Jul 2024$3.3B$871M – $6.7B$3.3B (0%)after a round930flatD0%
1 Aug 2024$3.3B$831M – $6.7B$3.3B (0%)after a round930flatD0%
1 Sep 2024$3.3B$1.1B – $6.7B$3.3B (0%)after a round1,100upC0%
24 Sep 2024$4.5B$3.9B – $6.7B$5.8B (+30%)after a round1,100upA0%
1 Oct 2024$4.5B$3.9B – $6.7B$5.8B (+29%)after a round1,100upA0%
1 Nov 2024$4.6B$3.9B – $6.7B$5.8B (+26%)after a round1,100upA0%
1 Dec 2024$4.7B$3.9B – $6.7B$5.8B (+24%)after a round1,100upA0%
1 Jan 2025$4.8B$3.9B – $6.7B$5.8B (+21%)after a round1,100upA0%
1 Feb 2025$4.9B$3.9B – $6.7B$5.8B (+18%)after a round1,100upA0%
1 Mar 2025$5.0B$3.9B – $6.7B$5.8B (+16%)after a round1,100upA0%
1 Apr 2025$5.2B$3.9B – $6.7B$5.8B (+13%)after a round1,100upA0%
1 May 2025$5.3B$3.9B – $6.7B$5.8B (+11%)after a round1,100upA0%
1 Jun 2025$5.4B$3.9B – $6.7B$5.8B (+9%)after a round1,100upA0%
1 Jul 2025$5.5B$3.9B – $6.7B$5.8B (+6%)after a round1,100upA0%
1 Aug 2025$5.7B$3.9B – $6.9B$6.0B (+4%)after a round1,211upA0%
1 Sep 2025$5.9B$3.9B – $6.9B$6.0B (+2%)after a round1,224upA0%
1 Oct 2025$6.0B$3.9B – $6.9B$6.0B (0%)after a round1,224upA0%
1 Nov 2025$5.8B$3.7B – $6.7B$5.8B (0%)after a round1,050flatA0%
1 Dec 2025$6.0B$3.8B – $6.9B$6.0B (0%)after a round1,266upA0%
1 Jan 2026$6.0B$3.8B – $6.9B$6.0B (0%)after a round1,266upB0%
1 Feb 2026$6.0B$3.8B – $6.9B$6.0B (0%)after a round1,266upB0%
1 Mar 2026$6.0B$3.7B – $6.9B$6.0B (0%)after a round1,266upB0%
19 Mar 2026$6.6B$5.7B – $8.3B$7.2B (+10%)after a round1,356upA0%
1 Apr 2026$6.6B$5.7B – $8.3B$7.2B (+10%)after a round1,356upA0%
1 May 2026$6.6B$5.7B – $8.3B$7.2B (+9%)after a round1,356upA0%
1 Jun 2026$6.7B$5.7B – $8.3B$7.2B (+8%)after a round1,356upA0%
26 Jun 2026$6.3B$5.5B – $9.4B$8.2B (+30%)after a round1,356upA0%
1 Jul 2026$6.3B$5.5B – $9.4B$8.2B (+29%)after a round1,356upA0%
1 Aug 2026$6.5B$5.5B – $9.4B$8.2B (+27%)after a round1,505upA0%
1 Sep 2026$6.6B$5.5B – $9.5B$8.2B (+24%)after a round1,531upA0%
1 Oct 2026$6.8B$5.5B – $9.6B$8.3B (+22%)after a round1,609upA0%
24 Oct 2026$6.9B$5.5B – $9.6B$8.3B (+20%)after a round1,609upA0%

Key facts about Alan

Founded
2016
Headquarters
Paris, France
Employees
about 1,610 +31% in a year
Total raised
$1.22B
Funding rounds
9
Last round
Series G Jun 2026

Alan was founded in 2016 by Charles Gorintin, Jean-Charles Samuelian-Werve and Nicolas Foroughi.

Alan funding history

Alan has 9 funding rounds on record, from Oct 2016 to Jun 2026, $1.22B in total. The latest disclosed valuation is $6.30B post-money (Series G, Jun 2026).

  1. Series G 25 Jun 2026

    Led by Prosus; with Ontario Teachers’ Pension Plan, Index Ventures, Dara Holdings.

    Sources: trendingtopics.eu, healthtechnerds.com

    $550M

    $6.30B post-money, below the round before

  2. Growth Equity 18 Mar 2026

    Led by Index Ventures; with Belfius, Greenoaks, KAAF Investments, SH Capital.

    Sources: researchmoneyinc.com, finance.yahoo.com, frenchtechupdates.beehiiv.com and 2 more

    $115M

    $6.57B post-money

  3. Series F 23 Sep 2024

    Led by Belfius; with Ontario Teachers’ Pension Plan, Temasek, Coatue, Lakestar.

    Sources: finsmes.com, techcrunch.com

    $193M

    $4.50B post-money

  4. Series E 12 Oct 2022

    With Origins Fund, Teampact Ventures.

    Sources: alan.com, verdict.co.uk, frenchhealthcare.com

    Amount undisclosed

  5. Series D 19 Apr 2021

    Led by Coatue; with Dragoneer Investment Group, Exor, Index Ventures, Ribbit, Temasek.

    Sources: partechpartners.com

    $222M

    $1.68B post-money

  6. Series C 20 Apr 2020

    Led by Temasek; with Index Ventures.

    Sources: finsmes.com, techcrunch.com, orrick.com

    $54M

  7. Series B 17 Feb 2019

    Led by Index Ventures; with DST Global.

    Sources: coverager.com, techcrunch.com, alexandre.substack.com

    $45M

  8. Series A 10 Apr 2018

    Led by Index Ventures; with Partech, Portage Ventures, Open CNP, Xavier Niel, Kima Ventures, Point Nine, Singular, Soma Capital, XAnge.

    Sources: alan.com, strictlyvc.com

    $28M

  9. Seed 25 Oct 2016

    Investors not disclosed.

    $13M

Alan investors

26 investors have backed Alan; Index Ventures, Temasek and Belfius and 2 more led at least one round.

What Alan does

Alan works in insurance - agents, carriers & brokers, with 13 recorded offerings and customers in healthcare, insurance and public sector.

Alan SA is a French public limited company engaged in health insurance and related services, including prevention, insurance, and daily support. The company serves businesses of all sizes and industries, as well as individuals such as retirees, self-employed workers, and public sector employees, offering health insurance, pension insurance, and preventive care. Alan also operates a digital wellness platform, a virtual clinic, and a wellness shop, and utilizes AI-powered technologies to enhance healthcare access and efficiency.

Description from Veridion's company data.

Products and services

  • Health Insurance Product Development
  • Health Insurance Distribution
  • Pension Insurance Product Development
  • Pension Insurance Distribution
  • Preventive Care Services
  • Digital Wellness Platform Services
  • Virtual Clinic Services
  • Wellness Product Retail
  • AI-Powered Healthcare Access Solutions
  • ESG-Focused Insurance Solutions
  • Tailored Health Insurance Solutions Development
  • Subscription-Based Health Services
  • Healthcare Professional Access Services

Markets

  • Healthcare
  • Insurance
  • Public Sector

Technology

  • AI-Powered Healthcare Access and Efficiency

Business model

  • Business-to-Business
  • Business-to-Consumer
  • Service Provider
  • Subscription-Based

Industry codes (NAICS)

  • 524114 Direct Health and Medical Insurance Carriers 50% match
  • 524113 Direct Life Insurance Carriers 20% match
  • 621999 All Other Miscellaneous Ambulatory Health Care Services 15% match
  • 456199 All Other Health and Personal Care Retailers 15% match

Questions about Alan

What is Alan worth?

Valuation $6.9B (range $5.5B to $9.6B), as of 24 Oct 2026. The last disclosed valuation was $6.30B (Series G, Jun 2026).

Has Alan raised money?

Alan has 9 funding rounds on record, from Oct 2016 to Jun 2026, $1.22B in total. The latest disclosed valuation is $6.30B post-money (Series G, Jun 2026).

Who has invested in Alan?

Index Ventures, Temasek, Belfius, Coatue, Prosus and Ontario Teachers’ Pension Plan, and 20 more. Lead investors include Index Ventures, Temasek, Belfius and Coatue.

How many people work at Alan?

About 1,610, up 31% over the last year. Headcount grew from 270 in Jan 2021 to 1,609 in Sep 2026.

What does Alan do?

Alan works in insurance - agents, carriers & brokers, with 13 recorded offerings and customers in healthcare, insurance and public sector. Its main offerings are health insurance product development, health insurance distribution and pension insurance product development.

When was Alan founded, and where is it based?

Alan was founded in 2016 and is based in Paris, France. It has about 1,610 employees, up 31% over the last year.

How we value companiesReport an issue